$IKT Inhibikase Therapeutics, Inc. - The CEO is making an
$IKT Inhibikase Therapeutics, Inc. - The CEO is making an important presentation today on the company's leading role in monoclonal antibody treatments for infectious diseases including the emerging Covid-19 Variants.
LD Micro Virtual Invitational XI
Date: Thursday, June 10, 2021
Time: 11:30am ET
Dr. Werner will present and discuss the clinical pharmacokinetics and adverse event profile of IkT-148009, the Company's lead asset being developed for the treatment of Parkinson's disease in the brain and gastrointestinal tract.
Webcasts of the presentations will be available for on-demand viewing under "News & Events" in the Investors section of the Company's website, www.inhibikase.com. An archived replay of the webcasts will be available for approximately 30 days following each event.
Scroll down for more posts ▼
Top 10 Most Recent News Articles
One map pin just disappeared from Chord Energy’s corporate wall, and that matters more than the usual deal-closing confetti. Chord has completed the sale of its entire non-operated Marcellus position to POSCO International for $550 million in gross consideration. For shareholders in NASDAQ:CHRD, this is not a flashy new drilling story. It is a cleanup job, and sometimes...
Continue Reading
Hong Kong’s awards roll call reads less like a scorecard than a map of where premium travel wants its money and attention to go next. The 2026 World’s Travel & Hotel Awards, released November 20, cast a very wide net: heritage palaces, city hotels, beach retreats, airlines, cruise operators, tourism boards, restaurants, serviced apartments and a fair number of...
Continue Reading
Endowment committees rarely need more noise; they need somebody who has actually sat through the uncomfortable votes. Mason Investment Advisory Services has hired Rebecca “Becky” Farnsworth, CFA, as a senior investment consultant, and this looks like a practical addition rather than the usual chest-thumping personnel announcement. Her stated focus will be...
Continue Reading
China's regulator moved faster than the calendar, and that is the one detail worth circling in red ink. Caliway Biopharmaceuticals has received authorization from the Center for Drug Evaluation under China's National Medical Products Administration to begin CBL-0102, its China study of injectable fat-reduction candidate CBL-514. For a clinical-stage company, an...
Continue Reading
Four ACP shares are about to become one, and the calculator crowd is liable to make a mountain out of a bookkeeping move. abrdn Income Credit Strategies Fund will execute a 1-for-4 reverse split before the opening bell on December 7, 2026. The quoted share price should rise by roughly four times, but the economic stake held by an investor does not magically get bigger...
Continue Reading
A boardroom rulebook is supposed to restrain power, not become a trapdoor under shareholders’ feet. That is the ugly governance question hanging over Fermi after the Texas Business Court dismissed Toby Neugebauer’s challenge to the company’s 70% supermajority bylaw. Neugebauer, Fermi’s co-founder and largest shareholder, says he will appeal. Frankly, he has every...
Continue Reading
A Real Customer Signal, Minus the Revenue Figure An updated image is the least interesting detail in this release. Sidus Space has landed a purchase order from Argotec Group to manufacture cable assemblies for the HAWK satellite platform, with delivery expected in the first quarter of 2027. That is a legitimate operational win for NASDAQ:SIDU. It brings in a new...
Continue Reading
Desert-colored booths do not pay invoices, but a nearly sold-out stash of spare units is a lot more useful than the usual trade-show applause. GEYOTO’s first RE+ appearance, held November 17–19 at the Las Vegas Convention Center, produced the kind of early evidence a young energy-products brand needs: people stopped, handled the equipment, asked questions, made...
Continue Reading
A week of bewildering infrastructure failures is a nasty time to discover nobody can explain the machinery. That was the backdrop for Atalanta CEO and co-founder Anjana Rajan at the National Academies of Sciences, Engineering, and Medicine's Cyber Resilience Forum, which concluded November 20 after two days in Washington. Her central point deserves more attention than the...
Continue Reading
Three million dollars changes the temperature in a research room, even if it does not magically solve the hard part. EB Research Partnership said its New York gala raised more than $3 million, with Eddie Vedder, Hozier, Tom Holland and Colin Farrell among the names helping draw attention. For a nonprofit operating around research, that is not a fluffy society-page...
Continue Reading
Top 5 Most Recently Viewed Articles
Yonder Media Mobile Initiates Lawsuit Against FuboTV In a recent announcement, Yonder Media Mobile Inc. ("YMM") has taken significant legal action against FuboTV, Inc. ("FuboTV"). This lawsuit contends that FuboTV has engaged in deceptive practices, causing substantial harm to YMM over an extended period. Serious Allegations of Misconduct The heart of the lawsuit revolves...
Continue Reading
What's Happening With United Airlines Stock? So, here's the scoop: United Airlines Holdings, Inc. (NASDAQ:UAL) is trying to claw back into the green after a rough patch, you know? Just yesterday, it took a dive—down almost 6%—all thanks to those pesky rising fuel costs. Crude oil prices are hitting six-month highs again, and yeah, that's got investors sweating over...
Continue Reading
Management's Bold Move in the Rights Issue Fingerprint Cards AB (publ) has taken a significant step in demonstrating their confidence in the company’s future. The CEO and CFO have decided to invest an impressive SEK 2 million in the ongoing rights issue without utilizing unit rights. This decision coincides with the company's efforts to raise approximately SEK 159.9...
Continue Reading
Investigation for Aehr Test Systems, Inc. Investors Glancy Prongay & Murray LLP, a prominent national law firm specializing in shareholder rights, has officially commenced an investigation into Aehr Test Systems, Inc. (NASDAQ: AEHR) on behalf of investors. This initiative aims to scrutinize potential violations of federal securities laws by the company. Why the...
Continue Reading
AB DAO and Bitget Join Forces for a Rewarding Initiative AB DAO is thrilled to reveal its newest collaboration with Bitget, a prominent name in the digital asset trading sphere. This partnership has led to the creation of a dual reward campaign, aimed at boosting user engagement and enhancing the overall ecosystem. The campaign will distribute a staggering total of...
Continue Reading